MODAG
PrivateLast Round
Grant
Dec 12, 2023
Total Funding Raised
$17.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MODAG operates in Healthcare & Life Sciences and is based in Wendelsheim. Its latest recorded funding round was a Grant round in December 2023.
MODAG is a biotechnology company that focuses on the research and development of therapeutics and diagnostics for neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Imaging
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MODAG Comparables
Compare MODAG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kainos Medicine Inc. | 84% | |
| Neuropore Therapies, Inc. | 83% | |
| Enterin | 83% |
For institutional investors. Book with your work email.
MODAG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 12, 2023 | ||||
| Grant | Aug 5, 2020 | ||||
| Series A | Jun 27, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MODAG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Max Planck Society for the Advancement of Science | Series A |
| Massa Investment AG | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 58% MoM, from 685 to 1.1K.
- May 18, 2026
Monthly visitors increased 31% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 8, 2026
MODAG GmbH is one of the winners of the CPHI Pharma Awards 2026, as Informa Markets recognizes its platform combining diagnostics and therapy in the API Development and Innovation category in Milan on Oct 6th '26.
- receives_awardOct 8, 2026
MODAG GmbH receives the CPHI Pharma Award in the API Development and Innovation category, with Informa Markets announcing the winners in Italy on Oct 6th '26.
For institutional investors. Book with your work email.
MODAG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MODAG's valuation, stock price, and market status.
Is MODAG a public or private company?
MODAG is a private company.
What is the current stock price of MODAG?
MODAG is a private company, so its shares have no public market price. Caplight tracks MODAG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MODAG worth (valuation)?
Valuation information for MODAG is not publicly available.
Can I buy MODAG stock?
MODAG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MODAG's last funding round?
MODAG's most recent funding round was Grant on December 12, 2023.
Who are the main investors in MODAG?
Key investors in MODAG include Massa Investment AG.
Will MODAG IPO soon?
No public IPO plans have been announced for MODAG.
How can I track MODAG secondary market activity?
Caplight tracks bids, offers, and trades in MODAG's shares on secondary markets.